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Polybrominated diphenyl ethers (PBDEs)
have been found in human breast milk
(Darnerud et al. 1998; Noren and Meironyte
1998, 2000). This route is a potential excre-
tion pathway for the mother and a route of
exposure to these compounds for the neonate.
Thus, the monitoring of breast milk provides
data for not only adult exposure but also
neonatal exposure.
Recently, an examination of Swedish
human milk samples from 1972 to 1997
revealed exponential increases in the concen-
trations of PBDEs (Darnerud et al. 1998;
Noren and Meironyte 1998, 2000). Deca-
BDE is used primarily in electrical and elec-
tronic applications (e.g., television housing,
wire and cable insulation) and to a lesser extent
in upholstery textiles. Penta-BDE was formerly
used in flexible polyurethane foam for cush-
ions. Octa-BDE was used in acrylonitrile-
butadiene-styrene resins intended for business
equipment housings. PBDEs are now found
as residues in sediment (Song et al. 2004); in
marine mammals, ﬁsh, and bird eggs (Covaci
et al. 2005; Kajiwara et al. 2004; Watanabe
et al. 2004); and in the breast milk, serum,
whole blood, and adipose tissue of humans
(Eslami et al. 2005; Koizumi et al. 2005;
Lind et al. 2003; She et al. 2002; Takasuga
et al. 2004). In contrast to PBDEs, banning
the production and use of polychlorinated
biphenyls (PCBs) in the 1970s has decreased
PCB serum levels and dietary exposure to
PCBs since the 1980s (Koizumi et al. 2005).
The aims of the present study were 2-fold.
The ﬁrst was to determine the current levels of
PBDEs and PCBs in Japanese women of
reproductive age and to analyze the effects of
lifestyle and dietary habits on these levels. The
second was to develop a quantitative struc-
ture–activity relationship (QSAR) model,
which enables us to predict the relationship
between serum and breast milk. The second
aim addresses the importance of translatability
between the serum and milk data.
Materials and Methods
Target populations. The present study was
approved by the Ethics Committee of the
Kyoto University Institutional Review Board,
and appropriate written informed consent
was obtained from all the participants before
sample collection.
After obtaining formal informed consent,
we collected blood and breast milk samples
from mothers who had delivered and were lac-
tating in maternity hospitals in four regions:
Sendai city (population, 1 million) in Miyagi
Prefecture, Takarazuka city (population,
250,000) in Hyogo Prefecture, Takayama city
(population, 200,000) in Gifu Prefecture, and
Shizunai-cho (population, 23,000) in
Hokkaido Prefecture.
Collection of serum samples and breast
milk samples. Milk samples were self-collected
manually into breast pumps with glass con-
tainers at the individual hospitals and trans-
ferred to 50-mL polypropylene conical tubes
(milk tube) that had been thoroughly rinsed
with methanol and acetone before use; sam-
ples were kept frozen at –20°C. The target
volume was > 20 mL from each mother per
sample. Blood samples (10 mL) were collected
into two 5-mL vacuum blood collection
polypropylene tubes (Venoject II; TERUMO
Inc., Tokyo, Japan) (blood tube) from cubital
vein by physicians or nurses. The blood and
milk samples were shipped within 48 hr to
Kyoto University. The serum samples were
separated by centrifugation at 3,000g for
15 min, transferred to new blood tubes, and
stored at –20°C in the Department of Health
and Environmental Sciences, Kyoto University
Graduate School of Medicine, until analysis.
When the milk samples were collected,
we asked the mothers to fill out question-
naires that contained necessary items for milk
surveillance (LaKind et al. 2004) and sources
of exposure to PBDEs (Ohta et al. 2002;
Sakai et al. 2001; Schecter et al. 2005;
Wilford et al. 2003), including the duration
of lactation, parity, residential history within
the previous 5 years, lifestyle and habits, and
Address correspondence to A. Koizumi, Department
of Health and Environmental Sciences, Kyoto
University Graduate School of Medicine, Yoshida
Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Telephone: 81-75-753-4456. Fax: 81-75-753-4458.
E-mail: koizumi@pbh.med.kyoto-u.ac.jp
*These authors contributed equally to this study.
Supplemental Material is available online at
http://www.ehponline.org/docs/2006/9032/suppl.pdf
This study was supported primarily by a Grant-
in-Aid for Health Sciences Research from the
Ministry of Health, Labor, and Welfare of Japan
(H15-Chemistry-004), but also received funding
from and by the Nippon Life Insurance Foundation
(Environment-04-08).
The authors declare they have no competing
ﬁnancial interests.
Received 21 January 2006; accepted 18 April 2006.
Levels and Concentration Ratios of Polychlorinated Biphenyls 
and Polybrominated Diphenyl Ethers in Serum and Breast Milk 
in Japanese Mothers
Kayoko Inoue,1* Kouji Harada,1* Katsunobu Takenaka,2 Shigeki Uehara,3 Makoto Kono,4 Takashi Shimizu,5
Takumi Takasuga,6 Kurunthachalam Senthilkumar,6 Fumiyoshi Yamashita,7 and Akio Koizumi1
1Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; 2Department of
Neurosurgery, Takayama Red Cross Hospital, Takayama, Japan; 3Department of Obstetrics and Gynecology, Tohoku Kosai Hospital,
Sendai, Japan; 4Kono Obstetrics and Gynecology Clinic, Shizunai, Japan; 5Shimizu Woman’s Clinic, Takarazuka, Japan; 6Shimadzu
Techno-Research Inc., Kyoto, Japan; 7Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
Blood and/or breast milk have been used to assess human exposure to various environmental
contaminants. Few studies have been available to compare the concentrations in one matrix with
those in another. The goals of this study were to determine the current levels of polybrominated
diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) in Japanese women, with analysis of
the effects of lifestyle and dietary habits on these levels, and to develop a quantitative structure–
activity relationship (QSAR) with which to predict the ratio of serum concentration to breast milk
concentration. We measured PBDEs and PCBs in 89 paired samples of serum and breast milk col-
lected in four regions of Japan in 2005. The geometric means of the total concentrations of PBDE
(13 congeners) in milk and serum were 1.56 and 2.89 ng/g lipid, respectively, whereas those of total
PCBs (15 congeners) were 63.9 and 37.5 ng/g lipid, respectively. The major determinant of total
PBDE concentration in serum and milk was the geographic area within Japan, whereas nursing dura-
tion was the major determinant of PCB concentration. BDE-209 was the most predominant PBDE
congener in serum but not in milk. The excretion of BDE 209 in milk was lower than that of BDE 47
and BDE 153. QSAR analysis revealed that two parameters, calculated octanol/water partition and
number of hydrogen-bond acceptors, were signiﬁcant descriptors. During the ﬁrst weeks of lactation,
the predicted partitioning of PBDE and PCB congeners from serum to milk agreed with the observed
values. However, the prediction became weaker after 10 weeks of nursing. Key words: breast milk,
partition coefficient, polybrominated diphenyl ethers, polychlorinated biphenyls, quantitative
structure–activity relationship, serum. Environ Health Perspect 114:1179–1185 (2006).
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Researchindoor environment (Supplemental Table 1;
available online at http://www.ehponline.
org/docs/2006/9032/suppl.pdf).
We prepared eight field blanks per site,
each consisting of an empty milk tube and an
empty blood tube. In addition, we prepared
eight milk tube/blood tube pairs filled with
5 mL of distilled water at the sampling site as
ﬁeld operational blanks. All the blank samples
were sent to Kyoto University and run
through complete extraction, cleanup, and
analysis procedures.
Serum extraction. The internal standard
from mono- to deca-13C12-PBDE and mono-
to deca-13C12-PCB was spiked in the serum
(3 g) and extracted by liquid–liquid extraction
following the method of Takasuga et al.
(2004, 2006). Briefly, in the serum spiked
with internal standard, 3 mL ammonium sul-
fate, 1 mL ethanol, and 2 mL hexane were
mixed and extracted twice. The final extract
was washed with hexane-washed water, dehy-
drated with sodium sulfate, and concentrated
to 5 mL for further cleanup.
Milk extraction. The internal standard
from mono- through deca-13C12-PBDE and
mono- to deca-13C12-PCB was spiked in the
milk (3 g) and extracted by liquid–liquid
extraction. Briefly, in the milk spiked with
internal standard, 1 mL saturated potassium
oxalate, 2 mL ethanol, 2 mL diethyl ether, and
1 mL hexane were mixed and extracted twice.
The ﬁnal extract was washed with 1 mL of 5%
sodium chloride and then dehydrated with
sodium sulfate and concentrated to 5 mL for
further cleanup.
Cleanup of serum and milk. The 5-mL
extract from serum or milk was subjected to
multilayer Florisil silica gel column cleanup
(Takasuga et al. 2004, 2006). The multilayer
cleaned samples were further concentrated to
the injection volume by nitrogen purge.
Identification and quantification of
PBDEs and PCBs. We used high-resolution
gas chromatography (HRGC; HP6890,
Agilent)/high-resolution mass spectrometry
(HRMS; Autospec Ultima; Micromass, Cary,
NC, USA) for analysis of PBDEs and PCBs.
Details on the HRGC/HRMS program are
reported elsewhere (Takasuga et al. 2004,
2006). Briefly, for PBDE analysis we used
either a BP-1 [15 m × 0.25 mm i.d. (0.1 μm);
SGE Analytical Science Pty. Ltd., Austin, TX,
USA] column or a ENV-5MS [15 m ×
0.25 mm i.d. (0.1 μm)] column. The column
was used with a temperature program of
120°C (1 min), increased 20°C/min to 160°C
(0 min), 10°C/min to 260°C (0 min), and
20°C/min to 300°C (8 min). For analysis of
PCBs, we used an HT-8 PCB column (60 m
× 0.25 mm i.d.; SGE Analytical), which was
used with an initial temperature of 150°C
(0 min), increased 20°C/min to 200°C
(0 min), 5°C/min to 260°C (0 min), and
10°C/min to 300°C (11.5 min). We used an
on-column injection program with a 2-μL
sample injection volume and with a resolu-
tion of M/ΔM > 10,000 (10% valley). We
determined the individual and total concen-
trations of 13 PBDE congeners [ΣPBDE13;
International Union of Pure and Applied
Chemistry (IUPAC) congeners 15, 28, 47,
99, 100, 153, 154, 183, 196, 197, 206, 207,
and 209] and 15 PCB congeners (ΣPCB15;
IUPAC congeners 74, 99, 118, 138, 146,
153, 156, 163/164, 170, 180, 182/187, 194,
199, 206, and 209).
The limit of detection (LOD) for each
PCB congener was 1 pg/g in both serum and
breast milk. The LOD of each PBDE congener
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Table 1. Characteristics of the participants.
Total Hokkaido Miyagi Gifu Hyogo p-Value
No. of participants 89 20 40 20 9
Age (years)
20–29 45 13 19 10 3 0.66
30–39 40 6 20 9 5
40–49 4 1 1 1 1
Mean ± SD 30.1 ± 4.6 27.7 ± 4.8 30.7 ± 4.1 30.0 ± 4.3 33.3 ± 4.5 0.01
Parity (mean ± SD) 1.45 ± 0.6 1.55 ± 0.8 1.33 ± 0.5 1.55 ± 0.7 1.56 ± 0.5 0.43
Nursing week at milk collection  13.6 ± 22.1 1.55 ± 1.6 12.0 ± 18.6 33.4 ± 30.3 3.11 ± 0.9 < 0.0001*
(mean ± SD)
Occupation [no. (%)]
Housewife 50 (56.2) 13 (65.0) 21 (52.5) 9 (45.0) 7 (77.8) 0.21
Ofﬁce worker 16 (18.0) 1 (5.0) 11 (27.5) 4 (20.0) 0
Technical professional 22 (24.7) 5 (25.0) 8 (20.0) 7 (35.0) 2 (22.2)
Farmer 1 (1.1) 1 (5.0) 0 0 0
Use electronic equipment [no. (%)]
Personal computer
Frequent use 43 (48.3) 4 (20.0) 27 (67.5) 8 (40.0) 4 (44.4) 0.004*
Rare use 46 (51.7) 16 (80.0) 13 (32.5) 12 (60.0) 5 (55.6)
Mobile phone
Frequent use 58 (65.2) 13 (65.0) 26 (65.0) 15 (75.0) 4 (44.4) 0.47
Rare use 31 (34.8) 7 (35.0) 14 (35.0) 5 (25.0) 5 (55.6)
Television
Frequent use 69 (77.5) 17 (85.0) 29 (72.5) 17 (85.0) 6 (66.7) 0.36
Rare use 20 (22.5) 3 (15.0) 11 (27.5) 3 (15.0) 3 (33.3)
Household furnishings [no. (%)]
Carpet
Frequent use 65 (73.0) 18 (90.0) 28 (70.0) 12 (60.0) 7 (77.8) 0.14
Rare use 24 (27.0) 2 (10.0) 12 (30.0) 8 (40.0) 2 (22.2)
Cushions
Frequent use 52 (58.4) 10 (50.0) 24 (60.0) 10 (50.0) 8 (88.9) 0.15
Rare use 37 (41.6) 10 (50.0) 16 (40.0) 10 (50.0) 1 (11.1)
Sofa
Frequent use 66 (74.2) 18 (90.0) 30 (75.0) 11 (55.0) 7 (77.8) 0.08
Rare use 23 (25.8) 2 (10.0) 10 (25.0) 9 (45.0) 2 (22.2)
Curtains
Frequent use 81 (91.0) 18 (90.0) 37 (92.5) 17 (85.0) 9 (100.0) 0.46
Rare use 8 (9.0) 2 (10.0) 3 (7.5) 3 (15.0) 0 (0.0)
Blinds
Frequent use 42 (47.2) 10 (50.0) 19 (47.5) 9 (45.0) 4 (44.4) 0.99
Rare use 47 (52.8) 10 (50.0) 21 (52.5) 11 (55.0) 5 (55.6)
Fish consumption (> once/week) [no. (%)]
Yellowtail and young yellowtail
Yes 14 (15.7) 0 (0.0) 4 (10.0) 8 (40.0) 2 (22.2) 0.003*
No 75 (84.3) 20 (100.0) 36 (90.0) 12 (60.0) 7 (77.8)
Mackerel
Yes 34 (38.2) 5 (25.0) 12 (30.0) 10 (50.0) 7 (77.8) 0.03
No 55 (61.8) 15 (75.0) 28 (70.0) 10 (50.0) 2 (22.2)
Salmon
Yes 56 (62.9) 13 (65.0) 30 (75.0) 9 (45.0) 4 (44.4) 0.30
No 33 (37.1) 7 (35.0) 10 (25.0) 11 (55.0) 5 (58.6)
Smoking status [no. (%)]
Nonsmoker 56 (62.9) 10 (50.0) 27 (67.5) 11 (55.0) 8 (88.9) 0.17
Ex-smoker 25 (28.1) 8 (40.0) 10 (25.0) 7 (35.0) 0 (0.0)
Current smoker 4 (4.5) 2 (10.0) 1 (2.5) 1 (5.0) 0 (0.0)
Passive smoker 4 (4.5) 0 (0.0) 2 (5.0) 1 (5.0) 1 (11.1)
Alcohol consumption [no. (%)]
Nondrinker 35 (39.3) 12 (60.0) 12 (30.0) 7 (35.0) 4 (44.4) 0.21
Ex-drinker 48 (53.9) 7 (35.0) 26 (65.0) 10 (50.0) 5 (55.6)
Current drinker 6 (6.7) 1 (5.0) 2 (5.0) 3 (15.0) 0 (0.0)
*p < 0.01; p-values were calculated for continuous values by ANOVA and for categorical values for the chi-square test or
Fisher’s exact test.in serum and milk was between 0.2 and 2 pg/g
for di-BDE to hepta-BDE and between 0.3
and 2 pg/g for octa-BDE to deca-BDE. The
serum and milk concentrations of PCBs and
PBDEs were expressed as nanograms per gram
lipid. The lipid content in the serum samples
was estimated from the total cholesterol and
triglyceride concentrations (Phillips et al.
1989). The lipid content of the milk samples
was determined from 2 mL crude extracts by
gravimetric method.
Quality assurance and quality control.
PBDE and PCB (native as well as 13C12-
labeled) standard solutions that contained the
major congeners of mono-BDE or mono-CB
to deca-BDE or deca-CB (> 95% pure) were
purchased from Wellington Laboratories
(Guelph, Ontario, Canada). The average recov-
ery of individual PBDE congeners was 54–84%
in serum (n = 100) and 54–103% in milk
(n = 100), and the average recovery of PCB
congeners was 61–79% in serum (n = 100) and
68–115% in milk (n = 100). The coefﬁcient of
variation for each determination was within
15% for both PBDEs and PCBs.
For all field blanks and field operational
blanks, all PBDE and PCB congeners were
< LOD. Operational blank tubes filled with
5 mL distilled water in an analytical laboratory
(Shimadzu Techno-Research Inc., Kyoto,
Japan) were also prepared for each eight-sam-
ple batch. These operational blanks were
< LOD for all PBDE and PCB congeners in
both the serum and milk batches. Thus, we did
not correct the results for background levels.
Structure–activity relationship. For the
QSAR analysis, we chose congeners that were
detected in > 50% of both the serum and milk
samples. Theoretical molecular descriptors for
the compounds, which included constitutional
descriptors, atom-centered fragments, and
molecular properties, such as hydrophilicity,
molar refractivity, polar surface area, and
octanol/water partition coefﬁcient (Kow), were
calculated using Dragon software (version 5.0;
Milano Chemo Metrics and QSAR Research
Group, Milan, Italy) and ADMET Predictor
1.2.3 (Simulations Plus, Lancaster, CA, USA).
The Kow calculated by Hansch’s method
(CLogP) and the molar refractivity calculated
by Hansch’s method (CMR) were calculated
using Web applications provided by Daylight
Chemical Information Systems (Aliso Viejo,
CA, USA). Descriptors that had a bivariate
correlation > 0.70 were removed.
We performed a stepwise multiple linear
regression analysis using the SAS statistical
package (version 8.2; SAS Institute Inc.,
Cary, NC, USA). All independent variables in
the regressions had a significance of at least
95%, based on Student’s t-score.
Statistical analysis. Statistical analyses were
conducted after logarithmic transformation of
the concentrations of the PBDEs and PCBs.
We tested differences between means by analy-
sis of variance (ANOVA) or Student’s t-test
when appropriate. A stepwise multiple regres-
sion analysis was used to explore determinants
for the serum and milk levels of contaminants
using a forward–backward stepwise regression
model (F-statistic to enter and stay in the
model with a p-value of < 0.25). We evaluated
the determinants for PBDEs and PCBs in
serum and breast milk using a conservative
approach based on multiple comparisons of
the questionnaire items. Thus, a p-value of
< 0.01 was considered signiﬁcant in the multi-
ple regression analysis for the questionnaire
items. For the other analyses, a p-value of
< 0.05 was considered signiﬁcant. All statistical
analyses were carried out with SAS software.
Results
Demographic features of the participants. On
the whole, there were 20 participants from
Hokkaido, 40 from Miyagi, 20 from Gifu, and
9 from Hyogo. The ages of the participants
ranged from 20 to 43 years (mean ± SD, 30.1
± 4.6 years). The results of the questionnaires
are summarized in Table 1.
Determination of PBDEs and PCBs in
serum and milk. The concentrations of some
congeners in the human samples were
< LOD. We treated these samples as 0 pg/g
lipid when we calculated the total amount.
The distributions of ΣPBDE13 in serum
and milk followed log-normal distributions
(Kolmogorov-Smirnov-Lilliefors test, p > 0.05).
The geometric mean (GM) values for the
total amounts of ΣPBDE13 in the milk and
serum samples were 1.56 and 2.89 ng/g lipid,
respectively (Table 2). The PBDE congener
levels and detection rates for milk and serum
are available online (Supplemental Tables 2
and 3, respectively; http://www.ehponline.
org/docs/2006/9032/suppl.pdf). BDE-209
was the predominant congener in serum and
accounted for 38% of the total PBDEs but
was a minor congener in milk and accounted
for 8% of the ΣPBDE13 (Figure 1A). In milk,
BDE-47 and BDE-153 were the major con-
geners and accounted for 28 and 23% of the
total PBDEs, respectively.
The distributions of the ΣPCB15 in serum
and milk also followed log-normal distributions
(Kolmogorov-Smirnov-Lilliefors test, p > 0.05).
The GM values for ΣPCB15 in the milk and
serum samples were 63.9 and 37.5 ng/g lipid,
respectively (Table 2). The PCB congener levels
and detection rates for milk and serum are
available online (Supplemental Tables 4 and 5,
respectively; http://www.ehponline.org/docs/
2006/9032/suppl.pdf). CB-153, CB-138, and
CB-180 were the major congeners in both milk
and serum (30, 17, and 13% of the total for
milk and 28, 16, and 15% of the total for
serum, respectively) (Figure 1B).
It should be noted that approximately the
same concentrations of the lighter PBDEs
(e.g., BDE-47) are present in serum and
milk, but BDE-209 is found at 10 times
lower concentrations in milk than in serum
(Supplemental Tables 2 and 3; available
online at http://www.ehponline.org/docs/
2006/9032/suppl.pdf). Likewise, almost dou-
ble the serum concentration of CB-153 is
PBDEs and PCBs in human serum and breast milk
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Table 2. Concentrations (ng/g lipid) of PBDEs or PCBs in human milk or serum samples.
No. of
Measure/area participants GM (GSD)a Mean ± SD Range Q25 Median Q75
PBDE in milk
Hokkaido 20 2.23 (1.47)A 2.39 ± 0.94 1.02–4.55 1.72 2.22 2.97
Miyagi 40 1.42 (1.56)B 1.55 ± 0.65 0.49–3.11 1.06 1.46 1.98
Gifu 20 1.45 (1.51)B 1.58 ± 0.71 0.82–3.30 1.01 1.40 2.00
Hyogo 9 1.30 (1.65)B 1.45 ± 0.70 0.66–2.38 0.83 1.31 2.31
Total 89 1.56 (1.59) 1.74 ± 0.81 0.49–4.55 1.13 1.54 2.24
PBDE in serum
Hokkaido 20 2.75 (1.47)AB 2.93 ± 1.04 1.04–5.43 2.24 2.96 3.50
Miyagi 40 3.64 (1.66)B 4.21 ± 3.14 1.33–21.19 2.68 3.56 4.93
Gifu 20 2.06 (1.55)A 2.24 ± 0.92 0.74–4.50 1.45 2.34 2.71
Hyogo 9 2.52 (1.76)AB 2.84 ± 1.32 0.76–5.38 1.78 3.13 3.41
Total 89 2.89 (1.68) 3.34 ± 2.37 0.74–21.19 2.16 2.99 3.76
PCB in milk
Hokkaido 20 58.91 (1.53)AB 64.50 ± 29.91 20–160 50.0  60.0  71.0
Miyagi 40 70.75 (1.56)B 78.48 ± 40.66 29–250 54.5  72.5  89.3
Gifu 20 47.24 (1.76)A 54.95 ± 30.17 18–130 33.3  51.5  72.0
Hyogo 9 94.64 (1.75)B 109.44 ± 58.41 39–190 65.0  93.0  170.0
Total 89 63.86 (1.69) 73.18 ± 40.90 18–250 47.0  65.0  88.0
PCB in serum
Hokkaido 20 35.92 (1.61)AB 40.65 ± 24.49 14–130 29.8  35.0  49.0
Miyagi 40 45.80 (1.72)B 53.00 ± 31.24 15–170 32.8  51.0  62.3
Gifu 20 22.26 (1.88)A 27.25 ± 18.86 7.9–82 14.0  22.0  35.5
Hyogo 9 54.32 (1.85)B 65.22 ± 40.67 23–130 34.0  50.0  89.0
Total 89 37.52 (1.89) 45.67 ± 30.58 7.9–170 26.0  38.0  57.0
Abbreviations: GSD, geometric SD; Q25, ﬁrst quartile; Q75, third quartile. 
aDifferent letters (A, B, or AB) indicate that the corresponding values are statistically different by Tukey’s HSD test after
ANOVA (p < 0.05).found in milk, whereas more than double the
milk concentration of CB-209 is found in
serum (Supplemental Tables 4 and 5; available
online at http://www.ehponline.org/docs/
2006/9032/suppl.pdf).
Determinants for PCBs and PBDEs in
serum and milk. We found signiﬁcant correla-
tions between ΣPCB15 and ΣPBDE13 levels in
both milk and serum (r2 = 0.194, p < 0.0001
for milk; r2 = 0.1808, p < 0.0001 for serum).
There were also signiﬁcant geographic differ-
ences in ΣPBDE13 concentrations in milk and
serum (ANOVA, p = 0.00095 and p =
0.00030, respectively; Table 2). The GM for
ΣPBDE13 in the milk samples was higher for
Hokkaido than for the other areas [Tukey’s
honest significant difference (HSD) test,
p < 0.05], whereas the GM for ΣPBDE13 in
serum samples was higher in Miyagi than in
Gifu (Tukey’s HSD test, p < 0.05). The PCB
levels also exhibited geographic differences
(ANOVA, p = 0.0029 for milk and p < 0.0001
for serum; Table 2). The GMs for ΣPBDE13
in both milk and serum samples were higher in
Miyagi and Hyogo than in Gifu (Tukey’s
HSD test, p < 0.05).
Multiple regression analysis revealed that
the geographic factor was the primary determi-
nant for the PBDE levels in both milk and
serum (data not shown). In contrast, nursing
duration was the significant determinant for
PCB levels in both serum and milk (data not
shown). To investigate the possible association
between hospitals and nursing durations, we
tested whether nursing duration was a determi-
nant for PBDE or PCB levels within a single
hospital. The nursing duration was correlated
with the ΣPBDE13 in serum in Miyagi
(n = 38, Kendall’s τ = –0.266, p = 0.0187) and
the ΣPCB15 in both serum and milk in Miyagi
(n = 38, Kendall’s τ = –0.426, p = 0.0002, and
Kendall’s τ = –0.312, p = 0.0059, respectively;
data not shown).
QSAR analysis. BDE-154, BDE-183,
BDE-196, and BDE-206 were eliminated
Inoue et al.
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Table 3. Correlation coefﬁcients between pairs of molecular descriptors or log P for PCBs and PBDEs.
log Kow CLogP MLogP MW MgVol CMR AMR PolarizG TPSA HBA nCL nBR
log Kow 1
CLogP 0.978 1
MLogP 0.899 0.948 1
MW 0.876 0.835 0.634 1
MgVol 0.900 0.866 0.677 0.998 1
CMR 0.967 0.958 0.832 0.956 0.972 1
AMR 0.968 0.960 0.836 0.954 0.970 1.000 1
PolarizG 0.964 0.954 0.823 0.961 0.975 1.000 1.000 1
TPSA 0.270 0.189 –0.125 0.667 0.631 0.437 0.430 0.450 1
HBA 0.270 0.189 –0.125 0.667 0.631 0.437 0.430 0.450 1.000 1
nCL –0.102 0.008 0.305 –0.540 –0.490 –0.270 –0.263 –0.286 –0.936 –0.936 1
nBR 0.648 0.570 0.301 0.928 0.903 0.778 0.773 0.788 0.871 0.871 –0.816 1
log P –0.891 –0.894 –0.731 –0.921 –0.933 –0.940 –0.939 –0.941 –0.499 –0.499  0.326 –0.777
Figure 2. Predicted and observed partition coefﬁcients (milk/serum) of PBDE and PCB congeners by nursing duration. (A) Weeks 0–1. (B) Weeks 2–10. (C) Weeks
11–88. The y-axis represents the predicted partition coefﬁcient, and the x-axis represents the ratio of the observed milk concentration to the observed serum con-
centration (mean ± SE). For (A), the relationship between the predicted (y) and observed (x) partition coefficients was y = 1.210x – 0.237 (r = 0.866, p < 0.001,
n = 26); for weeks 2–10 (B), y = 1.028x + 0.082 (r = 0.921, p < 0.001, n = 38); for weeks 11–88 (C), y = 0.717x + 0.233 (r = 0.824, p < 0.001, n = 25).
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Figure 1. Distributions of PBDE (A) and PCB (B) congeners in milk and serum from the 89 participants (mean ± SE). The levels of each congener are indicated as
the mean percentage of the ΣPBDE or ΣPCB concentration.from the analysis because of their low detection
rates in serum and/or milk (< 50%). In the
first step, we calculated the mean ratios of
milk concentrations (nanograms per gram
lipid) to serum concentrations (nanograms per
gram lipid) for individual congeners from
milk and serum as surrogates for their parti-
tion coefﬁcients (Supplemental Table 6; avail-
able online at http://www.ehponline.org/docs/
2006/9032/suppl.pdf). Using these mean
ratios, we then applied a multiple linear
regression analysis using various descriptors for
individual PCB and PBDE congeners. The
descriptors that have been used for QSAR
analysis include hydrophobicity [log Kow,
CLogP, (octanol/water partition coefficient
calculated by Hansch’s method), and MLogP
(octanol/water partition coefﬁcient calculated
by Moriguchi’s method)], size [MW (molecular
weight) and MgVol (molar volume calculated
by McGowan’s method)], polarizability
[CMR, (molar refractivity calculated by
Hansch’s method), AMR (calculated by
Ghose and Crippen’s method), and PolarizG
(polarizability calculated by Glen’s method)],
and constitutional descriptors [TPSA (topo-
logic polar surface area), HBA (number of
hydrogen-bond acceptors), nCL (number of
chlorines), and nBR (number of bromines)]
(Table 3) (Abraham and McGowan 1987;
Ghose and Crippen 1987; Glen 1994; Leo
et al. 1971; Moriguchi et al. 1994).
Table 3 summarizes the correlation coefﬁ-
cients between pairs of the descriptors,
together with regression coefﬁcients for each
descriptor. Regarding PCB and PBDE con-
geners, the descriptors for hydrophobicity
(log Kow, CLogP, and MLogP), molecular size
(MW and MgVol), and polarizability (CMR,
AMR, and PolarizG) were collinear, and each
correlated well with the milk/serum partition
coefﬁcient (log P). We explored the combina-
tion of the descriptors that exhibited the
highest multiple regression coefﬁcient (r) and
obtained the following equation:
log P = 1.664 – 0.1871 CLogP 
– 0.2092 HBA
(r = 0.955, F = 108.8, p < 0.001).  [1]
Because partition coefficients have been
reported to be dependent on the nursing
period (LaKind et al. 2004), we tested the
relationship between the predicted and
observed mean partition coefﬁcients for three
nursing durations (Figure 2). For nursing
durations ≤ 10 weeks, the partition coeffi-
cients predicted by the QSAR analysis agreed
with the observed values. However, the coefﬁ-
cient of x was smaller for nursing durations
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Table 4. PBDE levels in human milk and blood samples from different countries.
No. of  Year of  ΣPBDE (ng/g lipid) BDE-209
Country/type samples sampling  Mean Median mean PBDE congeners included in ΣPBDE Reference
Japan
Milk 105 2004 2.54 1.28 28, 47, 99, 100, 153, 154 Eslami et al. 2005
Milk 89 2005 1.74 1.54 0.12  15, 28, 47, 99, 100, 153, 154, 183, 196, 197, 206, 207, 209 Present study
Serum 40 1995 1.8 1.3 47, 99, 100, 153 Koizumi et al. 2005
Serum 89 2005 3.34 2.99 1.20  15, 28, 47, 99, 100, 153, 154, 183, 196, 197, 206, 207, 209 Present study
Milk 12 1999 1.72 28, 47, 99, 153, 154 Ohta et al. 2002
Milk 1(27)a 2000 1.39 0.04  28, 37, 47, 66, 75, 77, 85, 99, 100, 138, 153, 154, 183 Akutsu et al. 2003
Blood 156 1999–2001 13 6.9 9.20  3, 7, 15, 17, 28, 47, 49, 66, 71, 77, 85, 99, 100, 119, 126, 
138, 139, 153, 154, 183, 209 Takasuga et al. 2004
Milk 4 2003 1.04 17, 25, 28, 30, 32, 33, 35, 37, 47, 49, 66, 71, 75, 77, 85, 99,  Hirai et al. 2004
100, 116, 119, 126, 138, 153, 154, 155, 166
Blood 4 2003 0.3 17, 25, 28, 30, 32, 33, 35, 37, 47, 49, 66, 71, 75, 77, 85, 99,  Hirai et al. 2004
100, 116, 119, 126, 138, 153, 154, 155, 166
United States
Milk 47 2002 73.9 34 0.92  28, 47, 99, 100, 153, 154 Schecter et al. 2003
Milk 16 2004 77.5 48.5 0.38  28, 32, 33, 47, 66, 71, 85, 99, 100, 153, 154, 183, 209 She et al. 2004
Serum 93 2001–2003 24.6 47, 85, 99, 100, 153, 154, 183 Morland et al. 2005
Serum 7 2000–2002 61 17, 28, 47, 66, 85, 99, 100, 153, 154, 183, 203, 209 Sjödin et al. 2004
Serum 12 2001 37 47, 99, 100, 153, 154, 183 Mazdai et al. 2003
Canada
Milk 10 1992 5.65 3.03 28, 47, 99, 100, 153 Ryan and Patry 2000
Milk 98 2001–2002 22 28, 47, 99, 100, 153 Pereg et al. 2003
Plasma 10 1994–1999 23.3 20.3 28, 47, 85, 99, 100, 153, 154, 183 Ryan and van Oostdam 2004
Mexico
Milk 7 2003 4.4 0.30  47, 99, 100, 153, 154, 209 López et al. 2004
Plasma 5 2003 29.1 9.50  47, 99, 100, 153, 154, 209 López et al. 2004
United Kingdom
Milk 54 2001–2003 8.9 6.3 17, 28, 32, 35, 37, 47, 49, 71, 75, 85, 99, 100, 119, 153, 154 Kalantzi et al. 2004
Sweden
Milk 93 1996–1999 4.01 3.15 47, 99, 100, 153, 154 Lind et al. 2003
Serum 20 1997 3.3 47, 153, 154, 183, 209 Sjödin et al. 1999
Milk 15 2000–2001 2.14 17, 28, 47, 66, 85, 99, 100, 153, 154, 183 Guvenius et al. 2003
Plasma 15 2000–2001 2.07 17, 28, 47, 66, 85, 99, 100, 153, 154, 183 Guvenius et al. 2003
Norway
Serum 1(29)a 1999 3.34 28, 47, 99, 100, 153, 154 Thomsen et al. 2002
Finland
Milk 11 1994–1998 2.25 1.62 28, 47, 99, 153 Strandman et al. 2000
Germany
Milk 93 2001–2003 2.23 1.78 0.17  28, 47, 99, 153, 154, 183, 209 Vieth et al. 2004
Netherlands
Serum 78 2001–2002 10.7 9.3 47, 99, 100, 153, 154 Weiss et al. 2004
Spain
Milk 15 2002 2.41 1.7 15 congeners Schuhmacher et al. 2004
Italy
Milk 4(40)a 2000–2001 2.75 28, 47, 66, 85, 99, 100, 138, 153, 154, 183 Ingelido et al. 2004
aThe numbers of pooled samples are shown in parentheses.> 10 weeks, suggesting that the prediction
became weaker for longer nursing periods.
Discussion
In this article we have reported the current lev-
els of ΣPBDE13, including deca-BDE
(BDE-209), in serum and milk from Japanese
mothers. We found that BDE-209 was the
most abundant congener in serum but a minor
congener in milk. Its abundance in serum sug-
gests that wide industrial use of BDE-209 may
result in exposure (Watanabe and Sakai 2003).
Thus, low partitioning of this congener from
serum to milk might have resulted in the
underestimation of human adult exposure to
deca-BDE, if the exposure monitoring system
used was dependent solely on milk surveillance.
Table 4 shows the recent data on PBDEs
in breast milk and serum from 12 countries.
The current total PBDE levels in Japan are
signiﬁcantly lower than those in most Western
countries (Kalantzi et al. 2004; López et al.
2004; Mazdai et al. 2003; Morland et al.
2005; Pereg et al. 2003; Ryan and Patry 2000;
Ryan and van Oostdam 2004; Schecter et al.
2003; She et al. 2004; Sjödin et al. 2004) and
appear to be approximately equal to those of
Sweden (Guvenius et al. 2003; Kalantzi et al.
2004; Lind et al. 2003; Sjödin et al. 1999),
Spain (Schuhmacher et al. 2004), Italy
(Ingelido et al. 2004), Germany (Vieth et al.
2004), and Finland (Strandman et al. 2000).
Even for BDE-209, exposure was relatively
lower in Japan than in the United States and
Mexico. Even taking into account the varia-
tions in the measured PBDE congeners, the
above argument holds true.
We investigated factors that may influ-
ence the PBDE or PCB levels in serum and
milk. We found that the geographic factor
was the major determinant of PBDE levels in
Japan. In contrast, current nursing duration
was most significant for PCBs. Because the
current nursing duration was confounded by
the variation in the timing of milk collection
in the different hospitals, one could argue that
the apparent differences might be explained
partly by the geographic factor. However, the
current nursing duration remained signiﬁcant
for both PBDEs and PCBs even within sam-
ple series from a single hospital, indicating
that their concentrations became lower as the
nursing period became longer, as previously
reported by others (Wilson et al. 1985).
Human milk or serum surveillance is typi-
cally performed to monitor temporal changes
in the concentrations of environmental
chemicals or to compare the concentrations of
environmental chemicals among different
populations. However, only a few trials to
bridge the values for serum and milk have
been carried out for environmental chemicals
(Greizerstein et al. 1999). In contrast, there
have been several models and methods for
predicting drug transfer into human milk
(Fleishaker 2003) using the QSAR approach.
We applied the same approach for PCBs and
PBDEs. The analysis revealed that CLogP and
HBA are sufficient predictors of the transfer
from serum to milk. For PBDEs, the oxygen
atom bridging two halogenated aryl groups,
which functions as a hydrogen-bond acceptor,
appeared to reduce the transfer from serum to
milk. On the other hand, the model only
weakly predicted the partition coefﬁcients in
the later stages of nursing (≥ 11 weeks), as sug-
gested by Wilson et al. (1985). With the limi-
tation of the nursing period as a mode of
prediction by Equation 1, the present model
can be practically used for translating the con-
centrations in the two samples.
Conclusion
BDE-209 was the PBDE detected at the
highest concentration in serum of Japanese
lactating women, but its excretion in milk was
lower than that of the lower brominated
diphenyl ethers BDE-47 and BDE-153.
Geographic location within Japan and the
duration of nursing were discernible determi-
nants for levels of PBDEs and PCBs in
human serum and milk, respectively. The lev-
els of PBDEs in Japan were much lower than
those in the United States, Canada, and
Mexico but similar to those in European
countries. The application of QSAR for the
structure–partition relationship revealed that
the values for serum and milk are translatable
to each other.
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